Your browser doesn't support javascript.
loading
Efficacy and Safety of Sorafenib in a Racially Diverse Patient Population with Advanced Hepatocellular Carcinoma.
Schmidt, Timothy M; Liu, L I; Abraham, Ivy E; Uy, Almae B; Dudek, Arkadiusz Z.
Afiliação
  • Schmidt TM; Division of Academic Internal Medicine and Geriatrics, College of Medicine, University of Illinois at Chicago, Chicago, IL, U.S.A.
  • Liu LI; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, U.S.A.
  • Abraham IE; Division of Academic Internal Medicine and Geriatrics, College of Medicine, University of Illinois at Chicago, Chicago, IL, U.S.A.
  • Uy AB; University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, U.S.A.
  • Dudek AZ; HealthPartners Cancer Care Center, St. Paul, MN, U.S.A. arkadiusz.z.dudek@healthpartners.com.
Anticancer Res ; 38(7): 4027-4034, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29970527
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article